HQL6 serves as a novel P2Y14 receptor antagonist to ameliorate acute gouty arthritis through inhibiting macrophage pyroptosis
Mengze Zhou, Chunxiao Liu, Yanshuo Guo, Jialong Qian, Yuhang Wang, Zhenguo Zhang, Kun Hao, Cheng Jiang, Qinghua Hu
Topics & Concepts
PyroptosisMacrophageArthritisAntagonistReceptorMedicinePharmacologyChemistryImmunologyInternal medicineBiochemistryInflammasomeIn vitroGout, Hyperuricemia, Uric AcidInflammasome and immune disordersAdenosine and Purinergic Signaling